Publication | Closed Access

Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice

ThrombopoiesisThrombosisHematologyImmunologyPathologyHemostasisFactor ViiiAutoimmunityVascular BiologyCoagulopathyBleeding DisorderTransgenic ModelImmunotherapyMedicineCell TransplantationThrombotic Events